| The role of indoleamine-2, 3-dioxygenase in cancer development, diagnostics, and therapy L Hornyák, N Dobos, G Koncz, Z Karányi, D Páll, Z Szabó, G Halmos, ... Frontiers in immunology 9, 151, 2018 | 326 | 2018 |
| Ultraviolet radiation-mediated development of cutaneous melanoma: An update G Emri, G Paragh, Á Tósaki, E Janka, S Kollár, C Hegedűs, E Gellén, ... Journal of Photochemistry and Photobiology B: Biology 185, 169-175, 2018 | 102 | 2018 |
| Current translational potential and underlying molecular mechanisms of necroptosis T Molnár, A Mázló, V Tslaf, AG Szöllősi, G Emri, G Koncz Cell death & disease 10 (11), 860, 2019 | 101 | 2019 |
| The Fas/CD95 receptor regulates the death of autoreactive B cells and the selection of antigen-specific B cells G Koncz, AO Hueber Frontiers in immunology 3, 207, 2012 | 75 | 2012 |
| Immunomodulatory capacity of the serotonin receptor 5-HT2B in a subset of human dendritic cells A Szabo, P Gogolak, G Koncz, Z Foldvari, K Pazmandi, N Miltner, ... Scientific reports 8 (1), 1765, 2018 | 72 | 2018 |
| BCR mediated signal transduction in immature and mature B cells G Koncz, C Bodor, D Kövesdi, R Gáti, G Sármay Immunology letters 82 (1-2), 41-49, 2002 | 72 | 2002 |
| Human type II Fcγ receptors inhibit B cell activation by interacting with the p21ras-dependent pathway G Koncz, J Gergely Journal of Biological Chemistry 271 (48), 30499-30504, 1996 | 52 | 1996 |
| Co‐clustering of Fcγ and B cell receptors induces dephosphorylation of the Grb2‐associated binder 1 docking protein G Koncz, GK Tóth, G Bökönyi, G Kéri, I Pecht, D Medgyesi, J Gergely, ... European journal of biochemistry 268 (14), 3898-3906, 2001 | 48 | 2001 |
| Bacterially expressed human FcγRIIb is soluble and functionally active after in vitro refolding I Kurucz, A Hilbert, A Kapus, D Medgyesi, G Koncz, G Sármay, A Erdei, ... Immunology Letters 75 (1), 33-40, 2000 | 48 | 2000 |
| Fcγ receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell G Sarmay, G Koncz, I Pecht, J Gergely Immunology letters 57 (1-3), 159-164, 1997 | 37 | 1997 |
| Types of necroinflammation, the effect of cell death modalities on sterile inflammation A Mázló, V Jenei, S Burai, T Molnár, A Bácsi, G Koncz Cell Death & Disease 13 (5), 423, 2022 | 34 | 2022 |
| Grb2 associated binder 2 couples B-cell receptor to cell survival M Maus, D Medgyesi, D Kövesdi, D Csuka, G Koncz, G Sármay Cellular signalling 21 (2), 220-227, 2009 | 30 | 2009 |
| Fc gammaRIIb inhibits both B cell receptor-and CD19-induced Ca2+ mobilization in Fc gammaR-transfected human B cells. G Koncz, J Gergely, G Sármay International immunology 10 (2), 141-146, 1998 | 30 | 1998 |
| RIG-I inhibits the MAPK-dependent proliferation of BRAF mutant melanoma cells via MKP-1 A Szabo, T Fekete, G Koncz, BV Kumar, K Pazmandi, Z Foldvari, ... Cellular signalling 28 (5), 335-347, 2016 | 29 | 2016 |
| Caspase‐9 acts as a regulator of necroptotic cell death T Molnár, P Pallagi, B Tél, R Király, E Csoma, V Jenei, Z Varga, ... The FEBS Journal 288 (22), 6476-6491, 2021 | 27 | 2021 |
| The alternative splicing of human FcγRII mRNA is regulated by activation of B cells with mIgM cross‐linking, interleukin‐4, or phorbolester G Sármay, Z Rozsnyay, G Koncz, A Danilkovich, J Gergely European journal of immunology 25 (1), 262-268, 1995 | 27 | 1995 |
| Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the FcγRIIb mediated B cell regulation G Sármay, G Koncz, I Pecht, J Gergely Immunology letters 68 (1), 25-34, 1999 | 26 | 1999 |
| Integration of activatory and inhibitory signals in human B-cells G Sármay, G Koncz, J Gergely Immunology letters 54 (2-3), 93-100, 1996 | 26 | 1996 |
| Fcγ receptor‐mediated inhibition of human B cell activation: the role of SHP‐2 phosphatase G Koncz, I Pecht, J Gergely, G Sármay European journal of immunology 29 (6), 1980-1989, 1999 | 25 | 1999 |
| Multiple levels of immunological memory and their association with vaccination Z Bugya, J Prechl, T Szénási, É Nemes, A Bácsi, G Koncz Vaccines 9 (2), 174, 2021 | 21 | 2021 |
